Justera Health Ltd.
SCRSF
$0.0009
-$0.0094-91.26%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -62.17% | -74.34% | -86.67% | -87.50% | -68.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -62.17% | -74.34% | -86.67% | -87.50% | -68.03% |
| Cost of Revenue | -77.91% | -90.37% | -95.15% | -91.64% | -80.22% |
| Gross Profit | -37.61% | 2.09% | -18.95% | -67.81% | 710.47% |
| SG&A Expenses | 27.60% | -3.99% | -24.05% | -24.20% | -44.34% |
| Depreciation & Amortization | -79.68% | -63.40% | -64.12% | -65.92% | -78.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.05% | -58.66% | -70.67% | -70.48% | -71.21% |
| Operating Income | -61.64% | 18.68% | 32.65% | 7.96% | 77.17% |
| Income Before Tax | -16.66% | 67.18% | 62.98% | 44.80% | 70.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.44% | 68.12% | 63.63% | 45.52% | 70.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.44% | 68.12% | 63.63% | 45.52% | 70.90% |
| EBIT | -61.64% | 18.68% | 32.65% | 7.96% | 77.17% |
| EBITDA | -113.39% | 9.57% | 26.98% | -11.38% | 80.71% |
| EPS Basic | 15.12% | 72.85% | 71.15% | 59.29% | 86.83% |
| Normalized Basic EPS | -29.85% | 37.10% | 52.38% | 38.22% | 89.28% |
| EPS Diluted | 15.12% | 72.85% | 71.15% | 59.29% | 86.83% |
| Normalized Diluted EPS | -29.85% | 37.10% | 52.38% | 38.22% | 89.28% |
| Average Basic Shares Outstanding | 37.18% | 34.94% | 34.73% | 47.24% | 63.42% |
| Average Diluted Shares Outstanding | 37.18% | 34.94% | 34.73% | 47.24% | 63.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
